Male Infertility Industry Data Book - Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Jul, 2023
- Report ID: sector-report-00178
- Format: Electronic (PDF)
- Number of Pages: 350
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.2 Market Definition
- 1.3 Research Methodology
- 1.3.1 Information Procurement
- 1.3.1.1 Purchased database:
- 1.3.1.2 GVR’s internal database
- 1.3.2 Primary Research:
- 1.4 Research Scope and Assumptions
- 1.5 List of Data Sources
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Test Outlook
- 2.3 Treatment Outlook
- 2.4 End-use Outlook
- 2.5 Regional Outlook
- 2.6 Competitive Outlook
- 2.7 Male Infertility Market Snapshot
Chapter 3 Male Infertility Market Variables, Trends & Scope
- 3.1 Penetration and Growth Prospect Mapping
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.2.3 Market Challenges
- 3.3 Male Infertility Market Analysis Tools
- 3.3.1 Industry Analysis - Porter’s
- 3.3.1.1 Bargaining power of the suppliers -
- 3.3.1.2 Bargaining power of the buyers -
- 3.3.1.3 Threats of substitution -
- 3.3.1.4 Threats from new entrants -
- 3.3.1.5 Competitive rivalry -
- 3.3.2 PEST Analysis
- 3.3.2.1 Political Landscape
- 3.3.2.2 Economic Landscape
- 3.3.2.3 Social Landscape
- 3.3.2.4 Technology Landscape
- 3.4 Regulatory Landscape
- 3.5 Technology Landscape
- 3.5.1 Pipeline analysis (Upcoming technologies)
- 3.6 Impact of COVID-19 on the Male Infertility Market
Chapter 4 Male Infertility Market: Competitive Landscape Analysis
- 4.1 Recent Developments & Impact Analysis, by Key Market Participants
- 4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
- 4.3 Vendor Landscape
- 4.3.1 A partial list of key distributors and channel partners
- 4.3.2 Key customers
- 4.3.3 Key company market share analysis, 2022
- 4.3.4 Public Companies
- 4.3.4.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
- 4.3.4.2 Company market share analysis
- 4.3.4.3 Market differentiators
- 4.3.5 Private companies
- 4.3.5.1 List of key emerging companies
- 4.3.5.2 Regional network map
- 4.3.5.3 Company market position analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 5 Male Infertility Market Therapeutic Areas Analysis
- 5.1 Male Infertility Market: Therapeutic Areas Movement Analysis 2022 & 2030 (USD Million)
- 5.2 Diagnosis
- 5.2.1 Diagnosis market estimates and forecasts, by techniques, 2018 - 2030 (USD Million)
- 5.2.2 DNA Fragmentation Technique
- 5.2.2.1 DNA fragmentation technique market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.3 Oxidative Stress Analysis
- 5.2.3.1 Oxidative stress analysis market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.4 Microscopic Examination
- 5.2.4.1 Microscopic examination market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.5 Sperm Agglutination
- 5.2.5.1 Sperm agglutination market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.6 Computer Assisted Semen Analysis
- 5.2.6.1 Computer assisted semen analysis market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.7 Sperm Penetration Assay
- 5.2.7.1 Sperm penetration assay market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.8 Others
- 5.2.8.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3 Treatment
- 5.3.1 Treatment market estimates and forecasts, by procedure type, 2018 - 2030 (USD Million)
- 5.3.2 ART and varicocele surgery
- 5.3.2.1 ART and varicocele surgery market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.3 Medication
- 5.3.3.1 Medication market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Male Infertility Market End-use Analysis
- 6.1 Male Infertility Market: End-use Movement Analysis 2022 & 2030 (USD Million)
- 6.2 Fertility Clinics
- 6.2.1 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3 Hospitals
- 6.3.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Male Infertility Market: Regional Estimates & Trend Analysis, By Therapeutic Areas and End-use
- 7.1 Regional Market Snapshot
- 7.2 Male Infertility Market Share, By Region, 2022 & 2030 (USD Million)
- 7.3 Market Share Analysis, by Country, 2022
- 7.4 SWOT Analysis, by Factor (Political, Legal, Economic and Technological)
- 7.4.1 North America
- 7.4.2 Europe
- 7.4.3 Asia Pacific
- 7.4.4 Latin America
- 7.4.5 MEA
- 7.5 North America
- 7.5.1 North America male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2 U.S.
- 7.5.2.1 The U.S. male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Canada
- 7.5.3.1 Canada male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6 Europe
- 7.6.1 Europe male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2 UK
- 7.6.2.1 UK male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3 Germany
- 7.6.3.1 Germany male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4 Spain
- 7.6.4.1 Spain male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5 France
- 7.6.5.1 France male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6 Italy
- 7.6.6.1 Italy male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.7 Denmark
- 7.6.7.1 Denmark male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.8 Sweden
- 7.6.8.1 Sweden male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.9 Norway
- 7.9.7.1 Norway male infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7 Asia Pacific
- 7.7.1 Asia Pacific male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2 Japan
- 7.7.2.1 Japan male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.3 China
- 7.7.3.1 China male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.4 India
- 7.7.4.1 India male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.5 South Korea
- 7.7.5.1 South Korea male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.6 Thailand
- 7.7.6.1 Thailand male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.7 Australia
- 7.7.7.1 Australia male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8 Latin America
- 7.8.1 Latin America male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.2 Brazil
- 7.8.2.1 Brazil male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3 Mexico
- 7.8.3.1 Mexico male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4 Argentina
- 7.8.4.1 Argentina male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9 MEA
- 7.9.1 MEA male infertility Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.2 Saudi Arabia
- 7.9.2.1 Saudi Arabia male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.3 UAE
- 7.9.3.1 UAE male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.4 South Africa
- 7.9.4.1 South Africa male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.5 Kuwait
- 7.9.5.1 Kuwait male infertility Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
- 8.2 Vendor Landscape
- 8.2.1 Strategy Mapping
- 8.2.2 Launch of New Products
- 8.2.3 Merger and Acquisition
- 8.2.4 Product Approvals
- 8.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Strategic Initiatives)
- 8.4 Company Profiles
- 8.4.1 EMD Serono, Inc.
- 8.4.1.1 Company overview
- 8.4.1.2 Financial performance
- 8.4.1.3 Product benchmarking
- 8.4.1.4 Strategic initiatives
- 8.4.2 Endo International plc
- 8.4.2.1 Company overview
- 8.4.2.2 Financial performance
- 8.4.2.3 Product benchmarking
- 8.4.2.4 Strategic initiatives
- 8.4.2.5 SWOT analysis
- 8.4.3 Sanofi
- 8.4.3.1 Company overview
- 8.4.3.2 Financial performance
- 8.4.3.3 Product benchmarking
- 8.4.3.4 Strategic initiatives
- 8.4.3.5 SWOT Analysis
- 8.4.4 Bayer Group
- 8.4.4.1 Company overview
- 8.4.4.2 Financial performance
- 8.4.4.3 Product benchmarking
- 8.4.4.4 Strategic initiatives
- 8.4.4.5 SWOT analysis
- 8.4.5 SCSA Diagnostics
- 8.4.5.1 Company overview
- 8.4.5.2 Product benchmarking
- 8.4.6 Andrology Solutions
- 8.4.6.1 Company overview
- 8.4.6.2 Product benchmarking
- 8.4.7 Halotech DNA SL
- 8.4.7.1 Company overview
- 8.4.7.2 Product benchmarking
- 8.4.7.3 Strategic initiatives
- 8.4.8 Intas Pharmaceuticals Ltd.
- 8.4.8.1 Company overview
- 8.4.8.2 Financial performance
- 8.4.8.3 Product benchmarking
- 8.4.8.4 Strategic initiatives
- 8.4.8.5 SWOT analysis
- 8.4.9 Aytu BioScience, Inc.
- 8.4.9.1 Company overview
- 8.4.9.2 Financial performance
- 8.4.9.3 Product Benchmarking
- 8.4.9.4 Strategic initiatives
- 8.4.9.5 SWOT Analysis
- 8.4.10 Cadila Pharmaceuticals
- 8.4.10.1 Company overview
- 8.4.10.2 Product benchmarking
- 8.4.10.3 Strategic initiatives
- 8.4.11 Vitrolife
- 8.4.11.1 Company overview
- 8.4.11.2 Financial performance
- 8.4.11.3 Product benchmarking
- 8.4.11.4 Strategic initiatives
- 8.4.11.5 SWOT Analysis
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.